Here, we report the clinical courses of three patients receiving sirolimus who developed aggressive gastroduodenalulcer disease.
2
Ten controls were matched to each case of gastroduodenalulcer or upper gastrointestinal bleeding by age (year of birth), sex, and index date.
3
Conclusion: The risk of gastroduodenalulcers or upper gastrointestinal bleeding is significantly increased in patients using spironolactone.
4
The authors have analyzed their experiences with using endovideosurgical technologies in surgical treatment of 67 patients with perforation of gastroduodenalulcers.
5
Helicobacter pylori infection and the use of non-steroidal anti-inflammatory drugs (NSAIDs) can each result in gastroduodenalulcers and ulcer complications.
6
The results of treatment of 249 patients aged 15 to 78 years with perforated gastroduodenalulcers were analyzed.